BMO Capital Markets Boosts Oracle (NYSE:ORCL) Price Target to $275.00

Key Points

• BMO Capital Markets has increased its price target for Oracle (NYSE:ORCL) from $245.00 to $275.00, signaling an upside potential of 15.17% from the current price and maintaining an "outperform" rating.
• Multiple research firms have upgraded their price targets for Oracle, with TD Cowen setting a target of $325.00 and also a high number of analysts rating the stock as either a "Buy" or "Strong Buy."
• Oracle's recent quarterly earnings exceeded expectations, reporting $1.70 EPS and $15.90 billion in revenue, marking an 11.3% year-over-year revenue growth.

Oracle (NYSE:ORCL - Get Free Report) had its target price hoisted by equities research analysts at BMO Capital Markets from $245.00 to $275.00 in a research note issued to investors on Tuesday, Marketbeat.com reports. The firm presently has an "outperform" rating on the enterprise software provider's stock. BMO Capital Markets' price objective points to a potential upside of 15.17% from the company's current price.

Other research analysts have also issued reports about the company. TD Cowen boosted their price target on Oracle from $275.00 to $325.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Loop Capital set a $135.00 target price on Oracle in a research note on Tuesday, June 10th. Evercore ISI raised their price target on shares of Oracle from $215.00 to $270.00 and gave the company an "outperform" rating in a report on Monday, July 14th. Raymond James Financial reiterated a "strong-buy" rating on shares of Oracle in a research note on Wednesday, June 18th. Finally, JMP Securities raised their target price on shares of Oracle from $240.00 to $315.00 and gave the company a "market outperform" rating in a research note on Friday, July 18th. Two research analysts have rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and ten have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $235.61.

Oracle Price Performance

Shares of ORCL opened at $238.78 on Tuesday. The company has a debt-to-equity ratio of 4.07, a quick ratio of 0.75 and a current ratio of 0.75. The company has a 50 day moving average price of $239.78 and a 200-day moving average price of $187.22. Oracle has a fifty-two week low of $118.86 and a fifty-two week high of $260.87. The stock has a market capitalization of $670.70 billion, a PE ratio of 55.02, a PEG ratio of 3.47 and a beta of 1.46.

Oracle (NYSE:ORCL - Get Free Report) last issued its quarterly earnings data on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, topping analysts' consensus estimates of $1.64 by $0.06. The company had revenue of $15.90 billion during the quarter, compared to the consensus estimate of $15.58 billion. Oracle had a net margin of 21.68% and a return on equity of 87.34%. Oracle's revenue for the quarter was up 11.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.63 earnings per share. Equities analysts predict that Oracle will post 5 earnings per share for the current fiscal year.

Insider Buying and Selling at Oracle

In other news, Director Naomi O. Seligman sold 3,303 shares of the company's stock in a transaction on Wednesday, July 16th. The shares were sold at an average price of $233.32, for a total value of $770,655.96. Following the sale, the director directly owned 31,447 shares of the company's stock, valued at $7,337,214.04. This represents a 9.51% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Michael D. Sicilia sold 15,880 shares of the stock in a transaction on Tuesday, August 5th. The stock was sold at an average price of $254.48, for a total transaction of $4,041,142.40. Following the completion of the sale, the insider owned 99,212 shares in the company, valued at $25,247,469.76. The trade was a 13.80% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 444,183 shares of company stock worth $86,521,198. Corporate insiders own 42.20% of the company's stock.

Institutional Trading of Oracle

Hedge funds have recently modified their holdings of the stock. Norges Bank acquired a new stake in shares of Oracle during the 2nd quarter worth approximately $4,275,378,000. Nuveen LLC acquired a new stake in Oracle during the first quarter valued at $732,692,000. GAMMA Investing LLC grew its position in Oracle by 15,012.3% during the first quarter. GAMMA Investing LLC now owns 4,755,096 shares of the enterprise software provider's stock valued at $664,810,000 after buying an additional 4,723,631 shares during the period. Vanguard Group Inc. increased its holdings in Oracle by 2.2% in the first quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider's stock valued at $22,498,982,000 after buying an additional 3,513,464 shares in the last quarter. Finally, Kingstone Capital Partners Texas LLC acquired a new position in shares of Oracle in the second quarter worth about $731,512,000. Hedge funds and other institutional investors own 42.44% of the company's stock.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.